0:00
The FDA has approved the first mRNA-based seasonal flu vaccine
0:07
Trump administration's health officials on Wednesday approved Moderna's M. placebo vaccine for adults 50 and older
0:15
The approval comes with a condition. Moderna must complete an additional clinical trial to further study the vaccine in adults 65 and older
0:24
In a late-stage clinical trial, the shot was about 27% more effective than a standard flu vaccine
0:31
Like Moderna's COVID shots, it uses messenger RNA technology. The company says that platform can produce a new vaccine in about two to three months
0:41
compared with roughly six months for traditional egg-based flu vaccines, giving scientists a better chance to match the strains circulating each season
0:51
The approval comes after the FDA earlier this year delayed its review of the vaccine
0:56
before reversing course and moving ahead with the application. Ever wonder what we learned that doesn't make it into a two-minute story
1:04
That's what Offscript is all about. Longer conversations, extra reporting. And then to make things more complicated, environmental factors often interact with genetics
1:13
And the context behind the headlines from the people who know the stories best
1:17
President Trump chose to go to Michigan and make his presence felt and make himself part of the conversation there
1:24
Unbiased updates off script Thursdays at Straight Arrow
